PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Propaedeutics and Internal Medicine, Akhmet Yassawi Internationl Kazakh-Turkish University, Turkistan, Kazakhstan.\', \'Department of Biology, Faculty of Science and Technology, Universitas Islam Negeri Alauddin Makassar, South Sulawesi, Indonesia.\', \'Faculty of General Medicine, Belarusian State Medical University, Minsk, Belarus.\', \'Department of Prosthetic Dentistry, Sechenov First Moscow State Medical University, Moscow, Russian Federation.\', \'Stem Cell Research Center, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: Ahmadi.m@tbzmed.ac.ir.\', \'Department of Immunology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: Homayoon_siyahmansoori@yahoo.com.\']
?:citedBy
  • -1
?:creator
?:doi
  • S1521-6616(21)00049-810.1016/j.clim.2021.108712
?:doi
?:hasPublicationType
?:journal
  • Clinical immunology (Orlando, Fla.)
is ?:pmid of
?:pmid
?:pmid
  • 33684527
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Mesenchymal stem cell alongside exosomes as a novel cell-based therapy for COVID-19: A review study.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all